Association of polymorphisms in complement component C3 gene with susceptibility to systemic lupus erythematosus

Rheumatology

Volumn 47, Issue 2, 2008, Pages 158-164

  Miyagawa, Horiuchi ^a   Yamai, M ^b   Sakaguchi, D ^b   Kiyohara, C ^a   Tsukamoto, H ^a   Kimoto, Y ^a   Nakamura, T ^c   Lee, J H ^d   Tsai, C Y ^e   Chiang, B L ^d   Shimoda, T ^f   Harada, M ^a   Tahira, T ^b   Hayashi, K ^b   Horiuchi, T ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c Kumamoto Center for Arthritis and Rheumatology   (Japan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^e TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^f FUKUOKA NATIONAL HOSPITAL   (Japan)

Author keywords

Case Control study; Complement C3; Genetic analysis; SSCP; Systemic lupus erythematosus

Indexed keywords

CD134 ANTIGEN; CD28 ANTIGEN; CD40 LIGAND; COMPLEMENT COMPONENT C3; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DEOXYRIBONUCLEASE I; FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FAS LIGAND; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; MANNOSE BINDING LECTIN 2; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN BCL 2; PROTEIN KINASE FYN; TRANSCRIPTION FACTOR FLI 1; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ARTICLE; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; EXON; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENE LOCUS; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC IDENTIFICATION; GENETIC POLYMORPHISM; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; IMMUNOPATHOGENESIS; JAPANESE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS;

COMPLEMENT C3; COMPLEMENT SYSTEM PROTEINS; DNA; EXONS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKINS; JAPAN; LUPUS ERYTHEMATOSUS, SYSTEMIC; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROMOTER REGIONS (GENETICS);

EID: 38649122402     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kem321     Document Type: Article

References (32)

1. Kotzin BL. Systemic lupus erythematosus. Cell 1996;85:303-6.
2. Tsao BP. The genetics of human systemic lupus erythematosus. Trends Immunol 2003;24:595-602.
3. Wandstrat A, Wakeland E. The genetics of complex autoimmune diseases: non-MHC susceptibility genes. Nat Immunol 2001;2:802-9.
4. Tao K, Fujii M, Tsukumo SI et al. Genetic variation of Toll-like receptor 9 predispose to systemic lupus erythematosus in Japanese population. Ann Rheum Dis 2007;66:905-9.
5. Grumet FC, Coukell A, Bodmer JG, Bodmer WF, McDevitt HO. Histocompatibility (HL-A) antigens associated with systemic lupus erythematosus. A possible genetic predisposition to disease. N Engl J Med 1971;285:193-6.
6. Nath SK, Kilpatrick J, Harley JB. Genetics of human systemic lupus erythematosus: The emerging picture. Curr Opin Immunol 2004;16:794-800.
7. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1272-7.
8. Hochberg MC. Updating the American College of Rhoumatology revised driteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
9. Wakeland EK, Liu K, Graham RR, Behrens TW. Delineating the genetic basis of systemic lupus erythematosus. Immunity 2001;15:397-408.
10. Marrack P, Kappler J, Kotzin BL. Autoimmune disease: Why and where it occurs. Nat Med 2001;7:899-905.
11. Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: Integrating mammalian biology. Cell 2001;104:487-501.
12. Yasutomo K, Honuchi T, Kagami S et al. Mutation in DNASE I in people with systemic lupus erythematosus. Nat Genet 2001;28:313-4.
13. Sasaki T, Tahira T, Suzuki A et al. Precise estimation of allele frequencies of single-nucleotide polymorphisms by a quantitative SSCP analysis of pooled DNA. Am J Hum Genet 2001;68:214-8.
14. Babe S, Kukita Y, Higasa K, Tahira T, Hayashi K. Single-stranded conformational polymorphism analysis using automated capillary array electrophoresis apparatuses. Biotechniques 2003;34:746-50.
15. Higasa K, Kukita Y, Baba S, Hayashi K. Software for machine-independent quantitative interpretation of SSCP in capillary array electrophoresis (QUISCA). Biotechniques 2002;33:1342-8.
16. Stephens M, Donnelly P. A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003;73:1162-9.
17. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-5.
18. Sham P, Bader JS, Craig I, O'Donovan M, Owen M. DNA Pooling: A tool for large-scale association studies. Nat Rev Genet 2002;3:862-71.
19. Spector TD, Renelond RH, Mah S et al. Association between a variation in LRCH1 and knee osteoarthritis: A genome-wide single-nucleatide polymorphism association study using DNA pooling. Arthritis Rheum 2006;54:524-32.
20. Tahira T, Okazaki Y, Miura K et al. QSNPlite, a software system for quantitative analysis of SNPs based on capillary array SSCP analysis. Electrophoresis 2006;27:3869-78.
21. Sano Y, Nishimukai H, Kitamura H et al. Hereditary deficiency of the third component of complement in two sisters with systemic lupus erythematosus-like symptoms. Arthritis Rheum 1981;24:1255-60.
22. Pickering MC, Walport MJ. Links between complement abnormalities and systemic lupus erythematosus. Rheumatology 2000;39:133-41.
23. Tsukamoto H, Horiuchi T, Kokuba H et al. Molecular analysis of a novel hereditary C3 deficiency with systemic lupus erythematosus. Biochem Biophys Res Commun 2005;330:298-304.
24. Sohn J-H, Bora PS, Suk H-J, Molina H, Kaplan HJ, Bora NS. Tolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cells. Nat Med 2003;9:206-12.
25. Bowness P, Davies KA, Norsworthy PJ et al. Hereditary C1q deficiency and systemic lupus erythematosus. Q J Med 1994;87:455-64.
26. Ross SC, Densen P. Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency. Medicine 1984;63:243-73.
27. Sullivan KE. Complement deficiency and autoimmunity. Curr Opin Pediatr 1998;10:600-6.
28. Carroll MC. A protective role for innate immunity in systemic lupus erythematosus. Nat Rev Immunol 2004:4:825-31.
29. Davies EJ, Steers G, Ollier WE et al. Relative contributions of HLA-DQA and complement C4A loci in determining susceptibility to systemic lupus erythematosus. Br J Rheumatol 1995;34:221-5.
30. Doherty DG, Ireland R, Demaine AG et al. Major histocompatibility complex genes and susceptibility to systemic lupus erythematosus in southern chinese. Arthritis Rheum 1992;35:641-6.
31. Dunckley H, Gatenby PA, Hawkins B, Naito S, Serjeantson SW. Deficiency of C4A is a genetic determinant of systemic lupus erythematosus in three ethnic groups. J Immunogenet 1987;14:209-18.
32. Bijl M, Reefman E, Horst G, Limburg PC, Kallenberg CG. Reduced uptake of apoptotic cells by macrophages in systemic lupus erythematosus: correlates with decreased serum levels of complement. Ann Rheum Dis 2006;65:57-63.